Paul Krugman: The snake oil theory of the modern right
You don’t hear much these days about “economic anxiety.” Most observers acknowledge that the rise of the Trumpist right was driven by racial and social antagonism, not economic populism.
Yet there is an economic element to political extremism, just not what you’d think. Right-wing extremists, and to some extent even more mainstream conservative media, rely on financial support from companies selling nutritional supplements and miracle cures — and that financial support is arguably a significant factor pushing the right to become more extreme. Indeed, right-wing extremism isn’t just an ideological movement that happens to get a lot of money from sellers of snake oil; some of its extremism can probably be seen not as a reflection of deep conviction, but as a way of promoting snake oil.
Consider where we are right now in the fight against COVID-19. A few months ago it seemed likely that the development of effective vaccines would soon bring the pandemic to an end. Instead, it goes on, with hospitalizations closing in on their peak from last winter. This is partly due to the emergence of the highly contagious delta variant, but it also crucially reflects the refusal of many Americans to take the vaccines.
And much of this refusal is political. True, many people who are refusing to get vaccinated aren’t Trumpists, but there’s a strong negative correlation between Donald Trump’s share of a county’s vote and vaccinations. As of July, 86% of self-identified Democrats said they had had a vaccine shot, but only 54% of Republicans did.
But vaccine refusers aren’t just rejecting lifesaving vaccines, they’re also turning to life-threatening alternatives. We’re seeing a surge in sales of — and poisoning by — ivermectin, which is usually used to deworm livestock but has recently been touted on social media and Fox News as a COVID cure.
https://www.msn.com/en-us/news/opinion/paul-krugman-the-snake-oil-theory-of-the-modern-right/ar-AAOazod
= new reply since forum marked as read
